1
|
Abstract
To overcome the limitations of the current pertussis vaccines, those of limited duration of action and failure to induce direct killing of Bordetella pertussis, a synthetic scheme was devised for preparing a conjugate vaccine composed of the Bordetella bronchiseptica core oligosaccharide with one terminal trisaccharide to aminooxylated BSA via their terminal ketodeoxyoctanate residues. Conjugate-induced antibodies, by a fraction of an estimated human dose injected into young outbred mice as a saline solution, were bactericidal against B. pertussis, and their titers correlated with their ELISA values. The carrier protein is planned to be genetically altered pertussis toxoid. Such conjugates are easy to prepare, stable, and should add both to the level and duration of immunity induced by current vaccine-induced pertussis antibodies and reduce the circulation of B. pertussis.
Collapse
|
2
|
King AJ, van der Lee S, Mohangoo A, van Gent M, van der Ark A, van de Waterbeemd B. Genome-wide gene expression analysis of Bordetella pertussis isolates associated with a resurgence in pertussis: elucidation of factors involved in the increased fitness of epidemic strains. PLoS One 2013; 8:e66150. [PMID: 23776625 PMCID: PMC3679012 DOI: 10.1371/journal.pone.0066150] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2013] [Accepted: 05/01/2013] [Indexed: 12/11/2022] Open
Abstract
Bordetella pertussis (B. pertussis) is the causative agent of whooping cough, which is a highly contagious disease in the human respiratory tract. Despite vaccination since the 1950s, pertussis remains the most prevalent vaccine-preventable disease in developed countries. A recent resurgence pertussis is associated with the expansion of B. pertussis strains with a novel allele for the pertussis toxin (ptx) promoter ptxP3 in place of resident ptxP1 strains. The recent expansion of ptxP3 strains suggests that these strains carry mutations that have increased their fitness. Compared to the ptxP1 strains, ptxP3 strains produce more Ptx, which results in increased virulence and immune suppression. In this study, we investigated the contribution of gene expression changes of various genes on the increased fitness of the ptxP3 strains. Using genome-wide gene expression profiling, we show that several virulence genes had higher expression levels in the ptxP3 strains compared to the ptxP1 strains. We provide the first evidence that wildtype ptxP3 strains are better colonizers in an intranasal mouse infection model. This study shows that the ptxP3 mutation and the genetic background of ptxP3 strains affect fitness by contributing to the ability to colonize in a mouse infection model. These results show that the genetic background of ptxP3 strains with a higher expression of virulence genes contribute to increased fitness.
Collapse
Affiliation(s)
- Audrey J. King
- National Institute for Public Health and the Environment (RIVM), Laboratory for Infectious Diseases and Screening (LIS) Centre for Infectious Disease Control, Bilthoven, The Netherlands
- * E-mail:
| | - Saskia van der Lee
- National Institute for Public Health and the Environment (RIVM), Laboratory for Infectious Diseases and Screening (LIS) Centre for Infectious Disease Control, Bilthoven, The Netherlands
| | - Archena Mohangoo
- National Institute for Public Health and the Environment (RIVM), Laboratory for Infectious Diseases and Screening (LIS) Centre for Infectious Disease Control, Bilthoven, The Netherlands
| | - Marjolein van Gent
- National Institute for Public Health and the Environment (RIVM), Laboratory for Infectious Diseases and Screening (LIS) Centre for Infectious Disease Control, Bilthoven, The Netherlands
| | - Arno van der Ark
- National Institute for Public Health and the Environment (RIVM), Department of Vaccinology, Bilthoven, The Netherlands
| | - Bas van de Waterbeemd
- National Institute for Public Health and the Environment (RIVM), Department of Vaccinology, Bilthoven, The Netherlands
| |
Collapse
|
3
|
Dias AADSDO, Boller MAA, Werneck LMC, Hirata Junior R, Mattos-Guaraldi AL. Evaluation of respiratory model employing conventional NIH mice to access the immunity induced by cellular and acellular pertussis vaccines. Mem Inst Oswaldo Cruz 2006; 101:749-54. [PMID: 17160282 DOI: 10.1590/s0074-02762006000700007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2006] [Accepted: 09/13/2006] [Indexed: 11/22/2022] Open
Abstract
The increasing number of pertussis cases reported on the last twenty years and the existence of new acellular vaccines reinforce the need of research for experimental models to assure the quality of available pertussis vaccines. In this study, allotments of whole-cell and acellular pertussis vaccines were tested through the Intranasal Challenge Model (INM) using conventional NIH mice. The results have been compared to those achieved by the "Gold standard" Intracerebral Challenge Model (ICM). In contrast to ICM, INM results did not show intralaboratorial variations. Statistical analysis by Anova and Ancova tests revealed that the INM presented reproducibility and allowed identification and separation of different products, including three-component and four-component accellular pertussis vaccines. INM revealed differences between pertussis vaccines. INM provides lower distress to the mice allowing the reduction of mice number including the possibility of using conventional mice (less expensive) under non-aseptic environment. Thus, INM may be used as an alternative method of verifying the consistence of allotment production, including acellular pertussis vaccines.
Collapse
Affiliation(s)
- Alexandre Alves de Souza de Oliveira Dias
- Laboratório de Vacinas Bacterianas, Departamento de Imunologia, Instituto Nacional de Controle de Qualidade em Saúde, Fiocruz, 21040-900 Rio de Janeiro, RJ, Brazil.
| | | | | | | | | |
Collapse
|
4
|
Colombi D, Oliveira MLS, Campos IB, Monedero V, Pérez-Martinez G, Ho PL. Haemagglutination induced by Bordetella pertussis filamentous haemagglutinin adhesin (FHA) is inhibited by antibodies produced against FHA(430-873) fragment expressed in Lactobacillus casei. Curr Microbiol 2006; 53:462-6. [PMID: 17106803 DOI: 10.1007/s00284-005-0388-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2005] [Accepted: 03/15/2006] [Indexed: 11/28/2022]
Abstract
Filamentous haemagglutinin adhesin (FHA) is an important virulence factor from Bordetella pertussis related to the adhesion and spread of the bacteria through the respiratory tract. Three distinct domains have been characterized in mature FHA, and among them, the FHA(442-863) fragment was suggested to be responsible for the heparin-binding activity. In this study, we cloned the gene encoding the HEP fragment (FHA(430-873)) in a Lactobacillus casei-inducible expression vector based on the lactose operon. The recombinant bacteria, transformed with the resulting construct (L. casei-HEP), were able to express the heterologous protein depending on the sugar added to the culture. Subcutaneous inoculation of L. casei-HEP in Balb/C mice, using the cholera toxin B subunit as adjuvant, induced systemic anti-HEP antibodies that were able to inhibit in vitro erythrocyte haemagglutination induced by FHA. This is the first example of a B. pertussis antigen produced in lactic acid bacteria and opens new perspectives for alternative vaccine strategies against whooping cough.
Collapse
MESH Headings
- Adhesins, Bacterial/genetics
- Adhesins, Bacterial/immunology
- Adjuvants, Immunologic
- Animals
- Antibodies, Bacterial/genetics
- Antibodies, Bacterial/immunology
- Bordetella pertussis/immunology
- Female
- Hemagglutination/immunology
- Immunity, Mucosal
- Lac Operon
- Lacticaseibacillus casei/genetics
- Mice
- Mice, Inbred BALB C
- Pertussis Vaccine/immunology
- Protein Structure, Tertiary
- Recombinant Proteins/immunology
- Transformation, Bacterial
- Vaccines, Synthetic/immunology
- Virulence Factors, Bordetella/genetics
- Virulence Factors, Bordetella/immunology
- Whooping Cough/prevention & control
Collapse
Affiliation(s)
- Débora Colombi
- Centro de Biotecnologia, Instituto Butantan, São Paulo, Brazil
| | | | | | | | | | | |
Collapse
|
5
|
Knight JB, Huang YY, Halperin SA, Anderson R, Morris A, Macmillan A, Jones T, Burt DS, Van Nest G, Lee SF. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Clin Exp Immunol 2006; 144:543-51. [PMID: 16734625 PMCID: PMC1941966 DOI: 10.1111/j.1365-2249.2006.03097.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Bordetella pertussis is the causative agent of whooping cough, a major childhood pathogen; acellular vaccines consisting of purified B. pertussis antigens such as filamentous haemagglutinin (FHA) are commonly used to prevent pertussis. Despite the importance of FHA in B. pertussis pathogenesis and its inclusion in most acellular vaccines, the functional importance of individual domains in the induction of protective immunity is largely unknown. In this study, we have purified a recombinant FHA protein from Escherichia coli consisting of a 42 kDa maltose binding domain of E. coli and the 43 kDa type I immunodominant domain of FHA. The fusion protein (Mal85) was purified from E. coli cell lysates via affinity chromatography with an amylose column. Mal85 was then delivered to BALB/c mice intranasally encapsulated in liposomes, formulated with Protollin(TM) or in conjunction with an immunostimulatory CpG oligonucleotide. Mice were also vaccinated intraperitoneally with alum-adsorbed Mal85. Sera from all treatment groups showed strong IgG responses to Mal85 and recognized native FHA. Specific salivary IgA was induced in mice vaccinated with Mal85 in liposomes, Protollin(TM) and delivered with CpG. Vaccination with Mal85 encapsulated in liposomes or formulated with Protollin(TM) provided protection against aerosol challenge with B. pertussis in BALB/c mice. These data indicate that the type I domain of FHA is a protective antigen in mice and may serve as a candidate for inclusion in new acellular pertussis vaccines.
Collapse
MESH Headings
- Adhesins, Bacterial/immunology
- Adhesins, Bacterial/isolation & purification
- Adjuvants, Immunologic
- Animals
- Antibodies, Bacterial/biosynthesis
- Antigens, Bacterial/immunology
- Antigens, Bacterial/isolation & purification
- Bordetella pertussis/immunology
- CpG Islands/immunology
- Cysteine Endopeptidases
- Drug Combinations
- Female
- Hemagglutinins/immunology
- Hemagglutinins/isolation & purification
- Immunization/methods
- Immunoglobulin A, Secretory/biosynthesis
- Immunoglobulin G/biosynthesis
- Lipopolysaccharides
- Liposomes
- Mice
- Mice, Inbred BALB C
- Pertussis Vaccine/immunology
- Saliva/immunology
- Vaccines, Synthetic/immunology
- Virulence Factors, Bordetella/immunology
- Virulence Factors, Bordetella/isolation & purification
- Whooping Cough/prevention & control
Collapse
Affiliation(s)
- J B Knight
- Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University and the IWK Health Centre, Halifax, NS, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Gzyl A, Augustynowicz E, Gniadek G, Rabczenko D, Dulny G, Slusarczyk J. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine 2005; 22:2122-8. [PMID: 15149768 DOI: 10.1016/j.vaccine.2003.12.006] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2003] [Accepted: 12/02/2003] [Indexed: 11/30/2022]
Abstract
The present study indicates that the appearance of the B. pertussis harbouring prn2 gene allele variant (not found among clinical isolates before 1990s) may have been induced by long-term vaccination in Poland with DTP-composed vaccine strains presenting exclusively prn1. However, ptxS1A allele of pertussis toxin subunit S1 encoding gene, predominant in the currently isolated B. pertussis strains, has been found in vaccine strains used for whole-cell pertussis component (wP) production of DTP vaccine in 1960-1978. This outrules the possibility that the appearance of ptxSIA allele might be related to vaccine pressure driven by non-ptxS1A vaccine strains used for long-term immunization with wP. Intranasal challenge animal model testing the efficiency of the clearance of B. pertussis strains harbouring different ptxS1/prn allele gene combinations revealed that currently produced DTwP vaccine may not contain adequate B. pertussis vaccine strains, since isolates with gene variants different from those observed in vaccine strains were eliminated from the lungs of the immunized animals with lower efficiency.
Collapse
Affiliation(s)
- Anna Gzyl
- Department of Sera and Vaccines Evaluation, National Institute of Hygiene, Chocimska Street 24, 00-791 Warsaw, Poland.
| | | | | | | | | | | |
Collapse
|
7
|
Watanabe M, Komatsu E, Sato T, Nagai M. Evaluation of efficacy in terms of antibody levels and cell-mediated immunity of acellular pertussis vaccines in a murine model of respiratory infection. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 2002; 33:219-25. [PMID: 12110485 DOI: 10.1111/j.1574-695x.2002.tb00594.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The efficacy of six acellular pertussis vaccines, prepared by various manufacturers in Japan, was investigated in a murine model of respiratory infection (aerosol challenge model) and a murine intracerebral (i.c.) challenge model. There was a good correlation between bacterial clearance from the lungs after aerosol challenge and the potency of vaccines as determined by i.c. challenge. The levels of antibodies against filamentous hemagglutinin were higher after immunizations with all tested vaccines than the levels of antibodies against pertussis toxin and pertactin. Spleen cells from mice immunized with each individual vaccine secreted interferon gamma (IFN-gamma) in response to stimulation by pertussis toxin, filamentous hemagglutinin and fimbriae. The production of interleukin-4 in response to each of the antigens tested was detected but was lower than that of IFN-gamma. However, antibody levels and cell-mediated immune responses were not correlated with the protective effects of the vaccines after aerosol challenge and after i.c. challenge.
Collapse
Affiliation(s)
- Mineo Watanabe
- Department of Microbiology and Biologics, Daiichi College of Pharmaceutical Sciences, 22-1 Tamagawa-cho, Minami-ku, Fukuoka 815-8511, Japan.
| | | | | | | |
Collapse
|
8
|
Watanabe M, Nagai M. Effect of Acellular Pertussis Vaccine Against Various Strains of Bordetella Pertussis in a Murine Model of Respiratory Infection. ACTA ACUST UNITED AC 2002. [DOI: 10.1248/jhs.48.560] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Mineo Watanabe
- Department of Microbiology and Biologics, Daiichi College of Pharmaceutical Sciences
| | - Masaaki Nagai
- Division of Quality Control, Research Center for Biologicals, The Kitasato Institute
| |
Collapse
|